Guess that answers the question of will there be significant infringement of the use patent simply be marketing a generic. Hundreds of millions spent to comply with FDA to get the CV patent and to educate public and health officials going down the drain due to a lazy patent judge. Luckily the patent lawsuits keep the generic launch at risk.
Willful blindness by insurers looks like the most obvious court case.
Market Data 
Markets 
AI
